Global Next-Generation Sequencing Market Report to 2027 - Industry Trends, Share, Size, Growth, Opportunity and Forecasts - ResearchAndMarkets.com

·4 min read

DUBLIN, May 18, 2022--(BUSINESS WIRE)--The "Next-Generation Sequencing (NGS) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

The global next-generation sequencing (NGS) market reached a value of US$ 13.82 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 40.25 Billion by 2027, exhibiting a CAGR of 19.5% during 2022-2027.

Companies Mentioned

  • Agilent Technologies

  • Becton Dickinson

  • Company

  • 10x Genomics

  • BGI Group

  • Eurofins Scientific

  • F. Hoffmann-La Roche AG

  • Illumina Inc.

  • Genewiz

  • Macrogen

  • Oxford Nanopore Technologies

  • Pacific Biosciences

  • PerkinElmer

  • Thermo Fisher Scientific

  • Qiagen N.V.

  • GenapSys Inc.

Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Next-generation sequencing, or high-throughput sequencing, refers to the process of determining the sequence of nucleotides in a section of the DNA. It includes procedures such as sequencing by synthesis (SBS), ion semiconductor sequencing, nanopore sequencing and single-molecule real-time (SMRT) sequencing. It is a cost-effective solution that offers precise results with high accuracy and speed. This enables the analysis of millions of DNA molecules simultaneously, which facilitates research in the fields of personalized and genetic medicines, agriculture and animal research, and clinical diagnostics.

The increasing prevalence of chronic medical ailments, such as cancer, along with various technological advancements in the field of medical sciences, is one of the key factors driving the growth of the market. Owing to the widespread adoption of liquid biopsies in cancer diagnostics, there has been a significant increase in the utilization of NGS technologies. These technologies utilize cell-free circulating tumor DNA (ctDNA) as a non-invasive cancer biomarker for real-time cancer monitoring and detection.

Furthermore, the increasing adoption of genome mapping programs to predict the development of various diseases is also providing a boost to the market growth. Genetic maps are used for guiding scientists to analyze the genes that are responsible for increasing the prevalence of diabetes, heart diseases, asthma, cancer and psychiatric conditions.

Additionally, various technological advancements and integration with the cloud-computing systems for improved data management, are creating a positive impact on the market growth. Other factors, including the declining costs of NGS systems and extensive research and development (R&D) activities in the field of sequencing chemistry, molecular biology and technical engineering, are projected to drive the global next-generation sequencing market further.

Key Questions Answered in this Report1. What is the expected growth rate of the global next-generation sequencing (NGS) market?

2. What has been the impact of COVID-19 on the global next-generation sequencing (NGS) market?

3. What are the key factors driving the global next-generation sequencing (NGS) market?

4. What is the breakup of the global next-generation sequencing (NGS) market based on the sequencing type?

5. What is the breakup of the global next-generation sequencing (NGS) market based on the product type?

6. What is the breakup of the global next-generation sequencing (NGS) market based on the technology?

7. What is the breakup of the global next-generation sequencing (NGS) market based on the end-user?

8. What is the breakup of the global next-generation sequencing (NGS) market based on the application?

9. What are the key regions in the global next-generation sequencing (NGS) market?

10. Who are the key players/companies in the global next-generation sequencing (NGS) market?

Key Topics Covered:

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study

2.2 Stakeholders

2.3 Data Sources

2.3.1 Primary Sources

2.3.2 Secondary Sources

2.4 Market Estimation

2.4.1 Bottom-Up Approach

2.4.2 Top-Down Approach

2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview

4.2 Key Industry Trends

5 Global Next-Generation Sequencing Market

5.1 Market Overview

5.2 Market Performance

5.3 Impact of COVID-19

5.4 Market Forecast

6 Market Breakup by Sequencing Type

7 Market Breakup by Product Type

8 Market Breakup by Technology

9 Market Breakup by Application

10 Market Breakup by End-User

11 Market Breakup by Region

12 SWOT Analysis

13 Value Chain Analysis

14 Porters Five Forces Analysis

15 Price Indicators

16 Competitive Landscape

16.1 Market Structure

16.2 Key Players

16.3 Profiles of Key Players

For more information about this report visit https://www.researchandmarkets.com/r/4jj5il

View source version on businesswire.com: https://www.businesswire.com/news/home/20220518005641/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting